SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTheracryf PLC Share News (TCF)

Share Price Information for Theracryf PLC (TCF)

Share Price is delayed by 15 minutes
Get Live Data
0.235    -0.005 (-2.08%)
Bid:
0.23
Ask:
0.24
Spread: 0.01 (4.348%)
Market Cap: £5.05m
TCF Live PriceLast checked at - London Stock Exchange

Intraday Theracryf PLC Share Chart

Theracryf PLC News

TRADING UPDATES: Gem Resources raises funds; Afentra Angolan progress
4 Sep 2025

TRADING UPDATES: Gem Resources raises funds; Afentra Angolan progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TheraCryf confident as loss narrows but posts no revenue for 2025
3 Jun 2025

TheraCryf confident as loss narrows but posts no revenue for 2025

(Alliance News) - TheraCryf PLC on Tuesday reported it was in a good position despite "difficult markets" after narrowing its full-year loss.

TheraCryf partners with Pharmaron to develop addiction programme
12 May 2025

TheraCryf partners with Pharmaron to develop addiction programme

(Alliance News) - TheraCryf PLC on Monday said it has signed a master service agreement with Pharmaron UK Ltd to progress development of its Orexin-1 ...

TheraCryf signs deal for Ox-1 addiction treatment development
12 May 2025

TheraCryf signs deal for Ox-1 addiction treatment development

(Sharecast News) - TheraCryf announced on Monday that it has entered into a master service agreement with contract research organisation Pharmaron UK ...

TheraCryf narrows loss, advances drug programmes after acquisition
28 Nov 2024

TheraCryf narrows loss, advances drug programmes after acquisition

(Alliance News) - TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncology and neuropsy...

TheraCryf gets European patent for drug acquired from new subsidiary
27 Nov 2024

TheraCryf gets European patent for drug acquired from new subsidiary

(Alliance News) - TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug treating mental hea...